PNMT
Basic information
Region (hg38): 17:39667981-39670475
Previous symbols: [ "PENT" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PNMT gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 19 | 21 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 19 | 1 | 2 |
Variants in PNMT
This is a list of pathogenic ClinVar variants found in the PNMT region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-39668485-G-A | not specified | Uncertain significance (Apr 23, 2024) | ||
17-39668537-C-A | not specified | Uncertain significance (Apr 23, 2024) | ||
17-39668545-G-T | not specified | Uncertain significance (Oct 25, 2023) | ||
17-39668584-C-T | not specified | Uncertain significance (Jan 19, 2024) | ||
17-39668585-G-T | not specified | Uncertain significance (Jul 02, 2024) | ||
17-39668597-C-T | not specified | Uncertain significance (Jul 09, 2021) | ||
17-39668598-G-A | Benign (Apr 24, 2018) | |||
17-39668609-G-C | not specified | Uncertain significance (Dec 15, 2022) | ||
17-39668617-T-C | not specified | Uncertain significance (Nov 10, 2022) | ||
17-39668651-G-A | not specified | Uncertain significance (Dec 18, 2023) | ||
17-39669637-T-G | not specified | Uncertain significance (May 30, 2023) | ||
17-39669643-C-T | not specified | Uncertain significance (May 27, 2022) | ||
17-39669647-C-T | not specified | Uncertain significance (Dec 27, 2023) | ||
17-39669650-T-C | not specified | Uncertain significance (Sep 04, 2024) | ||
17-39669676-G-A | not specified | Uncertain significance (Jun 09, 2022) | ||
17-39669677-T-C | not specified | Uncertain significance (Jan 10, 2022) | ||
17-39669724-A-G | not specified | Uncertain significance (Jan 16, 2024) | ||
17-39669781-G-C | not specified | Uncertain significance (Sep 22, 2023) | ||
17-39669795-G-C | not specified | Uncertain significance (Jun 06, 2023) | ||
17-39669812-A-G | not specified | Uncertain significance (Dec 14, 2023) | ||
17-39670012-G-A | not specified | Uncertain significance (Dec 03, 2024) | ||
17-39670018-C-T | not specified | Uncertain significance (Jul 06, 2021) | ||
17-39670063-G-A | Benign (Jul 20, 2018) | |||
17-39670159-C-T | not specified | Uncertain significance (Sep 12, 2023) | ||
17-39670213-G-T | not specified | Uncertain significance (Dec 14, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PNMT | protein_coding | protein_coding | ENST00000269582 | 3 | 2495 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00501 | 0.896 | 125679 | 0 | 56 | 125735 | 0.000223 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.449 | 157 | 174 | 0.904 | 0.0000102 | 1777 |
Missense in Polyphen | 63 | 74.172 | 0.84938 | 810 | ||
Synonymous | 0.626 | 67 | 73.8 | 0.907 | 0.00000428 | 591 |
Loss of Function | 1.41 | 5 | 9.73 | 0.514 | 5.01e-7 | 96 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000465 | 0.000456 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000608 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000371 | 0.000360 |
Middle Eastern | 0.0000608 | 0.0000544 |
South Asian | 0.000164 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Converts noradrenaline to adrenaline.;
- Pathway
- Tyrosine metabolism - Homo sapiens (human);Tyrosine hydroxylase deficiency;Tyrosinemia, transient, of the newborn;Dopamine beta-hydroxylase deficiency;Disulfiram Action Pathway;Tyrosine Metabolism;Alkaptonuria;Monoamine oxidase-a deficiency (MAO-A);Hawkinsinuria;Tyrosinemia Type I;Catecholamine Biosynthesis;Aromatic L-Aminoacid Decarboxylase Deficiency;Amino Acid metabolism;Biogenic Amine Synthesis;Methylation Pathways;Metabolism of amino acids and derivatives;Metabolism;catecholamine biosynthesis;Catecholamine biosynthesis;Tyrosine metabolism;noradrenaline and adrenaline degradation;Amine-derived hormones
(Consensus)
Recessive Scores
- pRec
- 0.333
Intolerance Scores
- loftool
- 0.674
- rvis_EVS
- 0.06
- rvis_percentile_EVS
- 58.74
Haploinsufficiency Scores
- pHI
- 0.444
- hipred
- N
- hipred_score
- 0.251
- ghis
- 0.391
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.958
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pnmt
- Phenotype
- normal phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- methylation;epinephrine biosynthetic process;catecholamine biosynthetic process
- Cellular component
- cytoplasm;cytosol
- Molecular function
- phenylethanolamine N-methyltransferase activity